Peking Union Medical College Hospital: Prostatic Neoplasms trials
The registry lists 13 Prostatic Neoplasms studies with Peking Union Medical College Hospital as lead sponsor. 6 are open to participants now and 0 have results posted.
Early Phase 1 4Phase 1 5Phase 2 4Phase 3 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Not yet recruitingNCT07381582Early Phase 1
- [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate CancerEnrolling by invitationNCT06864572Early Phase 1
- 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate CancerRecruitingNCT06250244Phase 1/2
- Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsRecruitingNCT05841992Phase 2/3
- 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate CancerRecruitingNCT05613738Not applicable
- 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsRecruitingNCT05324332Not applicable
- 68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone MetastasisStatus unknownNCT05627778Phase 1/2
- Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPCStatus unknownNCT04996602Early Phase 1
- 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsStatus unknownNCT04796467Phase 2/3
- Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate CancerStatus unknownNCT03780075Phase 1
- 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate CancerStatus unknownNCT03403595Phase 1
- 68Ga-NOTA-RM26 PET/CT in Prostate Cancer PatientsStatus unknownNCT03164837Phase 1
- 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer PatientsStatus unknownNCT02747290Early Phase 1